DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 204 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $27,257,000 | -27.0% | 1,352,048 | +35.2% | 0.44% | -36.1% |
| Q2 2021 | $37,332,000 | -17.8% | 1,000,325 | -43.7% | 0.70% | -31.0% |
| Q1 2021 | $45,438,000 | +51.8% | 1,777,000 | +30.8% | 1.01% | +27.0% |
| Q4 2020 | $29,934,000 | +251.3% | 1,358,796 | +186.9% | 0.79% | +184.6% |
| Q3 2020 | $8,520,000 | -22.6% | 473,607 | +9.2% | 0.28% | -36.0% |
| Q2 2020 | $11,014,000 | -5.1% | 433,611 | -31.4% | 0.44% | -47.5% |
| Q1 2020 | $11,612,000 | +41.7% | 632,100 | +70.0% | 0.83% | +147.8% |
| Q4 2019 | $8,192,000 | – | 371,868 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,813,392 | $67,676,000 | 17.58% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $114,954,000 | 7.53% |
| RTW INVESTMENTS, LP | 7,521,859 | $280,716,000 | 4.24% |
| DAFNA Capital Management LLC | 510,756 | $19,061,000 | 3.99% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 229,892 | $8,580,000 | 3.83% |
| Parkman Healthcare Partners LLC | 304,686 | $11,371,000 | 2.49% |
| Evolutionary Tree Capital Management, LLC | 141,324 | $5,274,000 | 2.43% |
| Eagle Health Investments LP | 161,125 | $6,013,000 | 2.06% |
| Lombard Odier Asset Management (Switzerland) SA | 636,011 | $23,736,000 | 1.20% |
| Woodline Partners LP | 1,000,325 | $37,332,000 | 0.70% |